Back to search

National and Kapodistrian University of Athens

Κυτταρική μυοκαρδιοπλαστική με ενδοστεφανιαία χορήγηση αυτόλογων στελεχιαίων κυττάρων μυελού των οστών σε ασθενείς με καρδιακή ανεπάρκεια

Abstract

dc:description

The autologous transplantation of stem cells for cardiac repair is currently being investigatedas a potential treatment modality for patients with coronary artery disease. The rationale of thisnovel method is the enhancement of the natural repair mechanisms performed by tissue-specificand circulating stem/ progenitor cells. Contrary to the dogma that the heart is a terminallydifferentiated organ that cannot replace its own cell damage, there is now proof from preclinicalstudies that the circulating blood provides the injured tissue with adult stem and progenitorcells, which have the potential to differentiate into multiple cell lineages and ultimately improvecardiac function. Many questions regarding the exact mode of action remain unanswered.Most of the randomized controlled clinical studies conducted so far pertain to patients afterprimary percutaneous coronary intervention for acute myocardial infarction whereas patientswith chronic myocardial infarction or chronic myocardial ischemia have been studied mostlyin observational studies.The aim of our study was to test the safety and efficacy of intracoronary administration ofselected CD133+ and CD133-CD34+ bone marrow-derived bone marrow stem cells in patientswith old anterior, non viable myocardial infarction and abnormal ventricular function. Twenty fourpatients with old anterior non-viable myocardial infarction and left ventricular ejection fraction at baseline < 40% were included in the study. Twelve patients (11 male) underwent intracoronaryinfusion of 16.9±4.9x106 CD133+ and 8±4x106 selected CD133-CD34+ progenitor cells and 12patients were followed-up on medical therapy. The patients who underwent cell infusion were aged50.1±8.5 years old and had suffered from transmural anterior myocardial infarction 43.9±38.4months before therapy. The echocardiography protocol consisted of the echocardiography studymeasuring a) left ventricular volumes and left ventricular ejection fraction (at rest and afterinotropic challenge with low dose Dobutamine infusion) and b) longitudinal deformation indiceswith the Tissue Doppler Imaging (TDI) technique. The nuclear medicine protocol consisted ofTl-201 myocardial scintigraphy with reinjection. Both studies (echocardiography and nuclearmedicine) were performed at baseline and again at 4 and 11 months after cell therapy.Our results showed that patients in the treatment group showed a gradual and sustaineddecrease in left ventricular end-diastolic (p=0.008) and left ventricular end-systolic volume (p=0.002) as well as an increase in left ventricular ejection fraction (from 27.2±6.8% to 29.7±7.3%,p=0.016). We also noted an improvement in segmental anterior (p=0.005) and apical (p<0.001)wall perfusion. During 28±8.7 months of clinical follow-up one patient developed restenosis atthe site of cell delivery, another patient showed progression of atherosclerosis and a third oneexperienced deterioration of heart failure. The control group showed progressive (statisticallysignificant) increase of left ventricular volumes and a trend (p=0.11) towards a decrease ofglobal left ventricular ejection fraction. There was no evidence of increased arrhythmogenicity(24-hr Holter monitoring) after cell therapy.Data from the echocardiography study using Tissue Doppler Imaging (10 patients) revealedimprovement of longitudinal deformation indices 6 months after cell infusion. The improvementof PSySR (peak systolic strain rate) was the most consistent and pronounced effect of selectedbone marrow stem/progenitor cells infusion, increasing by 67% at rest and by 76% whencombined with inotropic challenge 6 months after therapy.Maximum strain during the cardiac cycle (εmax) and strain during ejection time (εet) improvedalso significantly during the rest study. Global left ventricular ejection fraction (p=0.061)and wall motion score index (p=0.66) didn’t improve significantly during the rest study, thusconfirming that strain is more accurate than 2D systolic wall analysis to depict regional wall motion abnormalities in coronary artery disease patients. Low-dose Dobutamine infusion alsoshowed improvement of longitudinal deformation indices (εmax) and global ejection fractionin the follow-up study.Data from the nuclear imaging studies (8 patients) revealed that labeling the cells beforeadministration is feasible with cell viability of 90% and labeling efficiency of approximately30%. After labeling the cells with 99mTc-hexamethylpropylenamineoxime (HMPAO) theywere successfully infused intracoronarilly without any complication. Scintigraphic images1 hour (8 patients) and 24 hours (4 patients) after infusion showed an uptake of 9.2±3.6%and 6.8±2.4% respectively of the total infused radioactivity in the infracted region.In conclusion, intracoronary infusion of selected CD133+ and CD133-CD34+ bone marrowstem/progenitor cells in patients with old, anterior non-viable myocardial infarction is safe,leads to sustained improvement in segmental perfusion and longitudinal deformation and exerts favorable effect on ventricular remodeling. Labeling of cells before administration was safe andfeasible and revealed migration and homing of transplanted cells to the infracted myocardialsegment.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Leontiadis, Evangelos
  • Λεοντιάδης, Ευάγγελος

Subjects

dc:subject × 10

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/40392

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Leontiadis, Evangelos; Λεοντιάδης, Ευάγγελος. Κυτταρική μυοκαρδιοπλαστική με ενδοστεφανιαία χορήγηση αυτόλογων στελεχιαίων κυττάρων μυελού των οστών σε ασθενείς με καρδιακή ανεπάρκεια. National and Kapodistrian University of Athens, 2014. http://hdl.handle.net/10442/hedi/40392